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ABSTRACT   
Breast calcification is one of the most important indicators for early breast cancer detection. In this study, based on a 
medical ultrasound array imaging platform, we attempt to develop a real-time and high penetration photoacoustic (PA) 
array imaging system for visualization of breast calcifications. Phantom studies were used to verify the imaging 
capability and penetration depth of the developed PA array system for calcification imaging. Intralipid gelatin phantoms 
with different-sized hydroxyapatite (HA) particles - major chemical composition of the breast calcification associated 
with malignant breast cancers - embedded were imaged. Laser at 750 nm was used for photoacoustic excitation and a 
custom-made 5-MHz photoacoustic array transducer with linear light guides was applied for photoacoustic signal 
detection. Experimental results demonstrated that this system is capable of calcification imaging of 0.3-0.5 mm HA 
particles. For the 0.5-mm HA particles, the imaging contrast was about 34 dB and the achievable penetration was 20 mm 
where the axial, lateral, and elevational resolution of this PA array imaging system is 0.39 mm, 0.38 mm, and 1.25 mm, 
respectively. The highest frame rate was 10 frames/sec limited by the laser pulse rate. Overall, our results demonstrate 
that it is promising for PA imaging as a real-time diagnosis and biopsy guidance tool of breast micro-calcifications 
outside mass lesion. Future work will focus on optimization of the photoacoustic transducer to further improve the 
penetration depth and development of photoacoustic and ultrasound dual-modal imaging to enhance the calcification 
imaging capability.  
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1. INTRODUCTION  
Calcification is one of the important indicators for early breast cancer detection [1]. Breast calcifications can be found in 
both benign and malignant lesions, and they can be the first and earliest sign of malignancy. X-ray mammography is the 
well-established gold standard method for identifying micro-calcifications. However, X-ray mammography is with 
ionizing radiation and thus there is inevitably carcinogenic risk. The use of ultrasound imaging is a powerful adjunct to 
X-ray mammography for imaging of breast lesions. Nonetheless, it is challenging for ultrasound imaging of micro-
calcifications. Speckle noise results in low ultrasound contrast between breast tissues and micro-calcification [2].  
Sickles pointed out that calcification particles smaller than 2 mm are unreliably detected using ultrasound [3]. Although 
state-of-the-art ultrasound imaging technology with higher probe frequency and spatial compounding may improve the 
visibility of micro-calcifications, generally it is difficult to detect micro-calcifications smaller than 0.5 mm [4], typically 
when they are located inside echogenic, fibro-glandular breast tissues instead of anechoic mass lesion.  
  
Photoacoustic (PA) imaging is an emerging bio-photonic imaging technique that overcomes the resolution 
drawback of pure optical imaging due to overwhelming light scattering in biological tissues, and possesses the merit of 
both optics and ultrasound – namely, high optical absorption contrast and sub-millimeter ultrasound resolution up to an 
imaging depth of few centimeters. PA signals are induced as a result of transient thermo-elastic expansion when 
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biological tissues absorb the pulsed laser energy. These signals are then detected by ultrasound transducers and 
reconstructed to form images representative of optical absorption distribution. PA imaging can potentially not only 
overcome the drawbacks of both mammography and ultrasound but also takes the advantages of wavelength selective 
high optical contrast and high ultrasonic resolution for detection of breast lesions and micro-calcificaitons. Preclinical 
studies on human breast cancer have shown that near-infrared (NIR) PA imaging can reveal vascular features suggestive 
of malignancy [5][6]. In our previous study, we also have demonstrated the feasibility of visualization of calcifications 
using PA imaing by a PA microscopy setup [7]. It is found that 0.5 mm micro-calcificaitons own comparable PA signal 
intensity with blood at NIR range which shows that PA imaging and biopsy guidance of breast micro-calcifications 
outside mass lesion is promising.  
 
In this study, we investigate the feasibility of real-time and deep-penetration PA micro-calcification imaging. 
Based on a medical ultrasound array imaging platform, we attempt to develop a real-time and high penetration PA array 
imaging system for visualization of breast calcifications. Phantom studies were used to verify the imaging capability and 
penetration depth of the developed PA array system for calcification imaging. 
2. MATERIALS AND METHODS 
2.1 Photoacoustic/Ultrasound Dual Modal Array Imaging System 
The setup of our developed photoacoustic/ultrasound dual modal array imaging system was shown in Fig. 1. An optical 
parametric oscillator (OPO) (Surlite OPO Plus, Continuum, USA) pumped by a frequency-tripled Q-switched Nd:YAG 
laser (Surlite II-10, Continuum, USA) was employed to provide laser pulses with a pulse width of ~4 ns and a pulse 
repetition rate of 10 Hz. Because of the relatively high penetration in tissue, laser light at NIR range was used. The NIR 
tunable range of the used OPO was about 750 nm to 850 nm where the output energy is stronger and relatively suitable 
for deep penetration imaging. According to our previous study [7], 750-nm laser light could induce stronger PA signals 
of hydroxyapatite (HA) particles – major chemical composition of the breast calcification associated with malignant 
breast cancers and owned less interference from blood; therefore, 750-nm laser was used as PA excitation source in this 
study. From the trend of the PA spectrum of HA calcifications obtained in our previous study, shorter wavelength, e.g., 
700 nm, might provide even stronger PA signals of HA calcifications. 
 
 For clinical use, it was preferred to integrate the ultrasound array probe and fiber bundles for laser delivery as a 
unit. Therefore, the used photoacsoutic transducer was composed of an 5-MHz ultrasound array probe (AT5L40B, 
Broadsound corporation) and two linear light guides, and was hold on a fixture connected to an X-Y-Z 3D motorized 
stage. The laser was coupled into the light guides and split to two sides of the ultrasound array probe. The cross of light 
beams from the two linear light guides was confocal with the elevational focal depth of the used ultrasound array probe. 
The tilting angles of the two linear light guides were adjustable in order to maximize the imaging depth. The maximum 
laser exposure on the phantom surface is about 5 mJ/cm2, which is less than the ANSI safety limite at 750 nm. The PA 
and ultrasound array signal detection was done with a PC-based ultrasound array data acquisition system – Verasonics 
V-1 (Verasonics Inc.). Image reconstruction was done on the control PC. Here delay-and-sum beamforming algorithm 
was employed. To obtain better image contrast, coherence weighting was applied in addition to delay-and-sum 
beamforming [8].  
 
 Without signal averaging, real-time imaging could be done with our PA/ultrasound dual modal imaging system. 
The achievable frame for PA B-mode imaging and PA/US coherent B-mode imaging was 10 frames/sec which was 
limited by the laser repetition rate. In addition to B-mode imaging, C-scan could be done by moving the photoacoustic 
transducer along the elevation direction with scanning range of 35 mm limited by the stage itself. At the depth of 20 mm, 
the maximum achievable axial and lateral resolution was 0.39 mm and 0.38 mm, respectively. The estimated elevation 
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Figure 1. Schematic diagram of the developed photoacoustic/ultrasound dual modal array imaging system 
 
2.2 Phantom Preparation 
According to the human tissue optics data [9][10], tissue-mimicking calcification phantoms were made from gelatin 
(gelatin, G2500-1KG, SIGMA) and intralipid (Lipovenoes 20%). The absorption coefficient and reduced optical 
scattering coefficient of the custom-made phantoms were 0.13 cm-1 and 8.9 cm-1, respectively. All the blood-loaded 
tubes and HA calcification particles are buried at the depth of 20 mm. The placement was shown in Fig. 2(a). Three 
blood-loaded tubes with 0.25-mm inner diameter and HA particles with about 1.5-mm, 0.5-mm and 0.3-mm size were 
placed at the same horizontal plane. Fig. 2(b) was the photograph of the custom-made tissue-mimicking phantom. In 
order to verify the object positions imaged by PA imaging with ultrasound, there were no acoustic scatterers added in our 
phantom. That is, the resultant ultrasound B-mode and C-scan images could be free of speckle noise; thus forming a 




Figure 2. Illustration of the custom-made tissue-mimicking optical phantom (a) Placement of HA calcifications and blood-loaded 
tubes at the plane at the depth of 20 mm. red lines and circles represent blood-loaded tubes and HA particles, respectively. (b) 
Photograph of the custom-made tissue-mimicking phantom 
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3. EXPERIMENTAL RESULTS 
Figure 3 shows the PA and ultrasound B-mode images captured by our PA/ultrasound dual modal array imaging system. 
These images are displayed on a 50-dB dynamic range. The top panels are the PA B-mode images and the bottom panels 
are the ultrasound B-mode image. B-mode images of HA calcification particles with size of 1.5 mm, 0.5 mm, 0.3mm are 
shown in the order from left to right. There is no speckle noise in the acquired ultrasound B-mode images because no 
acoustic scatterers are added into the phantom. Therefore, the blood-loaded tubes and HA particles are clearly shown in 
the ultrasound B-mode images. That is, the object positions imaged by PA imaging can be verified by ultrasound B-
mode images. PA imaging clearly visualizes all the HA calcification particles and blood-loaded tube at the depth of 20 
mm. The estimated contrast between the imaging objects and background are 39.0 dB for 1.5-mm HA, 34 dB for 0.5-mm 
HA, 11.5 dB for 0.3-mm HA, and 50.1 dB for blood-loaded tubes. Note that in this study, one hundred times signal 
averaging is performed to improve the imaging signal-to-noise ratio.  
 
 Figure 3. PA and ultrasound B-mode images of the custom-made tissue-mimicking phantom with HA particles and blood-loaded 
tube embedded. (a), (b), (c): PA B-mode images of 1.5-mm, 0.5-mm, and 0.3-mm HA particles, respectively. (d), (e), (f): ultrasound 
B-mode images of 1.5-mm, 0.5-mm, and 0.3-mm HA particles, respectively 
 
 Figures 3(a) and (b) show the projected PA and ultrasound C-scan images, respectively, in the depth ranging 
from 15 mm to 25 mm. These projected C-scan images are displayed on a 50-dB dynamic range. Fig. 3(c) is the 
photograph showing the placement of the embeded objects in the tissue-mimicking phantom at the depth of 20 mm. In 
comparison of Fig. 3(a) with Fig. 3(c), all the objects are clearly shown in their respective positions in the PA projected 
C-scan image. Results from the ultrasound projected C-scan image also validate those obtained from PA imaging. The 
results demonstrate that HA particles can generate comparable PA signal intensity to that of blood.The anisotropic 
resolution between lateral and elevation direction causes the dimension distortion of the imaged object. The object 
dimension are larger in elevation direction compared to that in lateral direction. 
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Fig. 4 The projected PA (a) and ultrasound (b) C-scan images in the depth range from 15 mm to 25 mm. (c) Photograph showing the 
placement of the embeded objects in the tissue-mimicking phantom. Note that in this photograph, the tubes are not loaded with blood. 
4. CONCLUSIONS  
Our experimental results demonstate that the developed PA/ultrasound dual modal array imaging system is capable of 
calcification imaging of 0.3-0.5 mm HA calcification particles. For the 0.5-mm HA particles, the imaging contrast was 
about 34 dB and the achievable penetration was 20 mm where the axial, lateral, and elevational resolution of this PA 
array imaging system is 0.39 mm, 0.38 mm, and 1.25 mm, respectively. The penetration depth is about adequate for 
imaging of breast calcifications, most of which appear at the depth from 15 mm to 35 mm [1]. The penetration depth is 
limited by the laser energy available in our current laser system and the coupling efficiency of the optical fiber bundles. 
In addition, from the trend of the PA spectrum of HA calcifications obtained in our previous study[7], shorter 
wavelength, i.e., 700 nm, might provide even stronger PA signals of HA calcifications. That is, deeper imaging depth for 
micro-calcifications may be achievable with shorter excitation wavelength, e.g., 700 nm, which is not available in our 
current laser system. Future work will focus on optimization of the photoacoustic transducer to further improve the 
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